COMPASS THERAPEUTICS, INC. Capital Expenditures
COMPASS THERAPEUTICS, INC. (CMPX) reported Capital Expenditures of $258.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-06
- COMPASS THERAPEUTICS, INC. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $176.00K.
- COMPASS THERAPEUTICS, INC. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $82.00K, a 355.56% increase year-over-year.
- COMPASS THERAPEUTICS, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $0.00.
- COMPASS THERAPEUTICS, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $7.00K, a 84.09% decline year-over-year.
- COMPASS THERAPEUTICS, INC. payments to acquire property, plant, and equipment for fiscal 2025 was $25.00K, a 43.18% decline from fiscal 2024.
- COMPASS THERAPEUTICS, INC. payments to acquire property, plant, and equipment for fiscal 2024 was $44.00K, a 46.67% increase from fiscal 2023.
- COMPASS THERAPEUTICS, INC. payments to acquire property, plant, and equipment for fiscal 2023 was $30.00K, a 85.85% decline from fiscal 2022.
- COMPASS THERAPEUTICS, INC. payments to acquire property, plant, and equipment for fiscal 2022 was $212.00K, a 86.48% decline from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $176.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $258.00K 10-Q · filed 2026-08-06 | $258.00K derived: sum of 3 quarters · filed 2026-08-06 | $265.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $82.00K 10-Q · filed 2026-05-05 | $82.00K derived: sum of 2 quarters · filed 2026-05-05 | $89.00K derived: sum of 3 quarters · filed 2026-05-05 | $89.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $7.00K derived: sum of 2 quarters · filed 2026-03-05 | $7.00K derived: sum of 3 quarters · filed 2026-08-06 | $25.00K 10-K · filed 2026-03-05 |
| 2025-09-30 | $7.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $7.00K derived: sum of 2 quarters · filed 2026-08-06 | $25.00K 10-Q · filed 2025-11-05 | $25.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $18.00K 10-Q · filed 2026-08-06 | $18.00K derived: sum of 3 quarters · filed 2026-08-06 | $62.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $18.00K 10-Q · filed 2026-05-05 | $18.00K derived: sum of 2 quarters · filed 2026-05-05 | $62.00K derived: sum of 3 quarters · filed 2026-05-05 | $62.00K derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $44.00K derived: sum of 2 quarters · filed 2026-03-05 | $44.00K derived: sum of 3 quarters · filed 2026-03-05 | $44.00K 10-K · filed 2026-03-05 |
| 2024-09-30 | $44.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $44.00K derived: sum of 2 quarters · filed 2025-11-05 | $44.00K 10-Q · filed 2025-11-05 | $53.00K derived: sum of 4 quarters · filed 2025-11-05 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $0.00 10-Q · filed 2025-08-11 | $9.00K derived: sum of 3 quarters · filed 2025-08-11 | $19.00K derived: sum of 4 quarters · filed 2025-08-11 |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-08 | $9.00K derived: sum of 2 quarters · filed 2025-05-08 | $19.00K derived: sum of 3 quarters · filed 2025-05-08 | $30.00K derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $19.00K derived: sum of 2 quarters · filed 2025-02-27 | $30.00K derived: sum of 3 quarters · filed 2025-02-27 | $30.00K 10-K · filed 2025-02-27 |
| 2023-09-30 | $10.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $21.00K derived: sum of 2 quarters · filed 2024-11-12 | $21.00K 10-Q · filed 2024-11-12 | $75.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $11.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $11.00K 10-Q · filed 2024-08-12 | $65.00K derived: sum of 3 quarters · filed 2024-08-12 | $92.00K derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-04 | $54.00K derived: sum of 2 quarters · filed 2024-03-21 | $81.00K derived: sum of 3 quarters · filed 2024-03-21 | $18.00K derived: sum of 4 quarters · filed 2024-03-21 |
| 2022-12-31 | $54.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $81.00K derived: sum of 2 quarters · filed 2024-03-21 | $18.00K derived: sum of 3 quarters · filed 2024-03-21 | $212.00K 10-K · filed 2024-03-21 |
| 2022-09-30 | $27.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$36.00K derived: sum of 2 quarters · filed 2023-11-09 | $158.00K 10-Q · filed 2023-11-09 | $935.00K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | -$63.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $131.00K 10-Q · filed 2023-08-03 | $908.00K derived: sum of 3 quarters · filed 2023-08-03 | $1.27M derived: sum of 4 quarters · filed 2023-08-03 |
| 2022-03-31 | $194.00K 10-Q · filed 2023-05-04 | $971.00K derived: sum of 2 quarters · filed 2023-05-04 | $1.34M derived: sum of 3 quarters · filed 2023-05-04 | $1.63M derived: sum of 4 quarters · filed 2023-05-04 |
| 2021-12-31 | $777.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $1.14M derived: sum of 2 quarters · filed 2023-03-15 | $1.44M derived: sum of 3 quarters · filed 2023-03-15 | $1.57M 10-K · filed 2023-03-15 |
| 2021-09-30 | $367.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $663.00K derived: sum of 2 quarters · filed 2022-11-09 | $791.00K 10-Q · filed 2022-11-09 | |
| 2021-06-30 | $296.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $424.00K 10-Q · filed 2021-08-16 | ||
| 2021-06-20 | $296.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-01 | $424.00K 10-Q · filed 2022-08-01 | $507.00K derived: sum of 3 quarters · filed 2022-08-01 | $514.00K derived: sum of 4 quarters · filed 2022-08-01 |
| 2021-03-31 | $128.00K 10-Q · filed 2022-05-09 | $211.00K derived: sum of 2 quarters · filed 2022-05-09 | $218.00K derived: sum of 3 quarters · filed 2022-05-09 | $222.00K derived: sum of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | $83.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-18 | $90.00K derived: sum of 2 quarters · filed 2022-03-18 | $94.00K derived: sum of 3 quarters · filed 2022-03-18 | $106.00K 10-K · filed 2022-03-18 |
| 2020-09-30 | $7.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $11.00K derived: sum of 2 quarters · filed 2021-11-12 | $23.00K 10-Q · filed 2021-11-12 | $208.00K derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-06-30 | $4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $16.00K 10-Q · filed 2021-08-16 | $201.00K derived: sum of 3 quarters · filed 2021-08-16 | $228.00K derived: sum of 4 quarters · filed 2021-08-16 |
| 2020-03-31 | $12.00K 10-Q · filed 2021-04-30 | $197.00K derived: sum of 2 quarters · filed 2021-04-30 | $224.00K derived: sum of 3 quarters · filed 2021-04-30 | |
| 2019-12-31 | $185.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-05 | $212.00K derived: sum of 2 quarters · filed 2021-03-05 | $466.00K 10-K · filed 2021-03-05 | |
| 2019-09-30 | $27.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $281.00K 10-Q · filed 2020-11-09 | ||
| 2019-06-30 | $254.00K 10-Q · filed 2020-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |